Former ByteDance AI scientist touts drug-discovery model that tops world leaders

Geodesic Intelligence, founded by former ByteDance AI scientist Quanquan Gu, released NovaAtom-Lite, a biomolecular structure and interaction prediction model that the firm says topped a third-party benchmark across several drug-discovery tasks, Gu said on social media on Wednesday. The model's results on FoldBench were cited as evidence it outperforms state-of-the-art systems, intensifying competition in AI-driven drug discovery.

A former ByteDance artificial intelligence scientist’s new venture has released a life sciences AI model that the firm claims outperforms state-of-the-art systems, intensifying the increasingly crowded competition in AI-driven drug discovery. Geodesic Intelligence’s NovaAtom-Lite, an AI model designed to predict the structures and interactions of biomolecules, topped a third-party benchmark in several drug discovery tasks, founder Quanquan Gu said on social media on Wednesday. On the FoldBench...